Projects Showing 1 - 17 out of 17 results Filter by Program - Any -Aboriginal and Torres Strait Islander Health ProgramBiosecurity ProgramBiostatistics and Databases ProgramGlobal Health ProgramHIV Epidemiology and Prevention ProgramImmunovirology and Pathogenesis ProgramInfection Analytics ProgramSexual Health ProgramSurveillance and Evaluation Research ProgramTherapeutic and Vaccine Research ProgramViral Hepatitis Clinical Research ProgramViral Hepatitis Epidemiology and Prevention ProgramViral Immunology Systems Program Keywords Focus areas - Any -Aboriginal and Torres Strait Islander healthCOVID-19 and emerging infectionsGlobal healthHIVHPVSexual healthViral hepatitis Research strengths - Any -Biostatistics, modelling and analysisCapacity buildingClinical trials and cohortsEpidemiology and surveillanceHealth economics and health systemsImmunovirologyNew diagnostic approachesPublic health interventionsSocial and behavioural sciences View more Sort by Earliest firstLatest firstTitle A - ZTitle Z - A Phylogeography of Emerging Infectious Diseases The CIRCUIT Study Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy INSIGHT14_TICO Evolution of HIV Natural history cohort following SARS-CoV-2 infection Development of antiviral RNA therapeutics for COVID-19 treatment delivered via nanoparticle inhalation Engineering monoclonal antibodies for COVID-19 protection and therapy Harnessing antibodies to treat COVID-19 Gene delivery Understanding the dynamics of host-immunity and drug action in malaria Understanding HIV reactivation and latency Use of next generation sequencing to understand host-virus interactions in hepatitis C infection Characterising B cell responses to hepatitis C virus infection SiRNA Project Contribution of T follicular helper cells to recrudescence from the latent HIV-1 reservoir HIV, Immunity and Cancer Biobank (HI-C)
Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy
Development of antiviral RNA therapeutics for COVID-19 treatment delivered via nanoparticle inhalation
